143 related articles for article (PubMed ID: 21253648)
1. The Haptoglobin β chain as a supportive biomarker for human lung cancers.
Kang SM; Sung HJ; Ahn JM; Park JY; Lee SY; Park CS; Cho JY
Mol Biosyst; 2011 Apr; 7(4):1167-75. PubMed ID: 21253648
[TBL] [Abstract][Full Text] [Related]
2. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
3. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
4. [Detection of serum CK19-2G2 and Cyfra21-1 protein and comparison of their diagnostic value for lung cancer].
Gao J; Wang H; Qi J
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):930-2. PubMed ID: 19173996
[TBL] [Abstract][Full Text] [Related]
5. 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins.
Dowling P; O'Driscoll L; Meleady P; Henry M; Roy S; Ballot J; Moriarty M; Crown J; Clynes M
Electrophoresis; 2007 Dec; 28(23):4302-10. PubMed ID: 18041032
[TBL] [Abstract][Full Text] [Related]
6. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.
Hoagland LF; Campa MJ; Gottlin EB; Herndon JE; Patz EF
Cancer; 2007 Nov; 110(10):2260-8. PubMed ID: 17918261
[TBL] [Abstract][Full Text] [Related]
7. Identification of serum proteome components associated with progression of non-small cell lung cancer.
Pietrowska M; Jelonek K; Michalak M; Roś M; Rodziewicz P; Chmielewska K; Polański K; Polańska J; Gdowicz-Kłosok A; Giglok M; Suwiński R; Tarnawski R; Dziadziuszko R; Rzyman W; Widłak P
Acta Biochim Pol; 2014; 61(2):325-31. PubMed ID: 24872961
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.
Tsai HY; Boonyapranai K; Sriyam S; Yu CJ; Wu SW; Khoo KH; Phutrakul S; Chen ST
Proteomics; 2011 Jun; 11(11):2162-70. PubMed ID: 21538882
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
10. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.
Sung HJ; Ahn JM; Yoon YH; Rhim TY; Park CS; Park JY; Lee SY; Kim JW; Cho JY
J Proteome Res; 2011 Mar; 10(3):1383-95. PubMed ID: 21141971
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF].
Zhao Q; Duan W; Wu YM; Qian XH; Deng XH
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):754-8. PubMed ID: 19173805
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum mitochondrial DNA in lung cancer.
Hou YL; Chen JJ; Wu YF; Xue CJ; Li FZ; Zheng Q; Chen H
Clin Biochem; 2013 Oct; 46(15):1474-7. PubMed ID: 23611926
[TBL] [Abstract][Full Text] [Related]
14. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.
Feng JT; Liu YK; Song HY; Dai Z; Qin LX; Almofti MR; Fang CY; Lu HJ; Yang PY; Tang ZY
Proteomics; 2005 Nov; 5(17):4581-8. PubMed ID: 16240287
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
16. Value of tumour and inflammatory markers in lung cancer.
Oremek GM; Sauer-Eppel H; Bruzdziak TH
Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
Zhang S; Ma Y; Yang X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
[TBL] [Abstract][Full Text] [Related]
18. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
19. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
Gencer M; Ceylan E; Aksoy N; Uzun K
Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
[TBL] [Abstract][Full Text] [Related]
20. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
